RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells. - GreenMedInfo Summary
RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide.
Cancer Lett. 2018 Jul 1 ;425:31-42. Epub 2018 Mar 30. PMID: 29608987
RIP1 and RIP3 are necroptosis initiators, but their roles in regulation of glycolysis remain elusive. In this study, we found shikonin activated RIP1 and RIP3 in glioma cells in vitro and in vivo, which was accompanied with glycolysis suppression. Further investigation revealed that shikonin-induced decreases of glucose-6-phosphate and pyruvate and downregulation of HK II and PKM2 were significantly prevented when RIP1 or RIP3 was pharmacologically inhibited or genetically knocked down with SiRNA. Moreover, shikonin also triggered accumulation of intracellular HOand depletion of GSH and cysteine. Mitigation of intracellular HOvia supplement of GSH reversed shikonin-induced glycolysis suppression. The role of intracellular HOin regulation of glycolysis suppression was further confirmed in the cells treated with exogenous HO. Notably, inhibition of RIP1 or RIP3 prevented intracellular HOaccumulation, which was correlated with preventing shikonin-induced downregulation of x-CT and depletion of GSH and cysteine. In addition, supplement of pyruvate effectively inhibited shikonin- or exogenous HO-induced accumulation of intracellular HOand glioma cell death. Taken together, we demonstrated in this study that RIP1 and RIP3 contributed to shikonin-induced glycolysis suppression via increasing intracellular HO.